申请人:LILLY CO ELI
公开号:WO2000039118A1
公开(公告)日:2000-07-06
This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
本申请涉及公式 I 的化合物(或其药学上可接受的盐),其制药组合物以及其作为因子 Xa 抑制剂的用途,以及其制备过程和中间体。